Author details

Full Name

Tatiana Kisseleva

Affiliation

ORCID

Career Start Year

1995

Papers

118

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37743012	The Origin and Fate of Liver Myofibroblasts.	Cell Mol Gastroenterol Hepatol	2024
36599008	An autocrine signaling circuit in hepatic stellate cells underlies advanced fibrosis in nonalcoholic steatohepatitis.		2023
37405925	Isolation of primary human liver cells from normal and nonalcoholic steatohepatitis livers.		2023
37084733	Fructose-1,6-bisphosphatase is a nonenzymatic safety valve that curtails AKT activation to prevent insulin hyperresponsiveness.		2023
36893735	Candida albicans-specific Th17 cell-mediated response contributes to alcohol-associated liver disease.	Cell Host Microbe	2023
36811393	IgY antibodies against cytolysin reduce ethanol-induced liver disease in mice.	Hepatology	2023
37247063	Human Hepatic Stellate Cells: Isolation and Characterization.		2023
35921818	Aberrant iron distribution via hepatocyte-stellate cell axis drives liver lipogenesis and fibrosis.		2022
36358290	The Role of Mesothelin in Activation of Portal Fibroblasts in Cholestatic Liver Injury.	Biology	2022
35700738	MiR-690 treatment causes decreased fibrosis and steatosis and restores specific Kupffer cell functions in NASH.	Cell Metab	2022
36001995	Metabolic Injury of Hepatocytes Promotes Progression of NAFLD and AALD.	Semin Liver Dis	2022
35605662	Selective PPARÎ´ agonist seladelpar suppresses bile acid synthesis by reducing hepatocyte CYP7A1 via the fibroblast growth factor 21 signaling pathway.	J Biol Chem	2022
34879108	PNPLA3 downregulation exacerbates the fibrotic response in human hepatic stellate cells.	PLoS ONE	2021
34130335	Interleukin-17 in Liver Disease Pathogenesis.	Seminars in Liver Disease	2021
33540107	Previous liver regeneration induces fibro-protective mechanisms during thioacetamide-induced chronic liver injury.	International Journal of Biochemistry and Cell Biology	2021
34119473	Nondegradable Collagen Increases Liver Fibrosis but Not Hepatocellular Carcinoma in Mice.	Am J Pathol	2021
34062281	Nonalcoholic Steatohepatitis and HCC in a Hyperphagic Mouse Accelerated by Western Diet.	Cell Mol Gastroenterol Hepatol	2021
33724957	Bile acid-activated macrophages promote biliary epithelial cell proliferation through integrin Î±vÎ²6 upregulation following liver injury.	J Clin Invest	2021
34253615	Immunotherapy-based targeting of MSLN<sup>+</sup> activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis.	Proc Natl Acad Sci U S A	2021
33550587	Heterogeneity of HSCs in a Mouse Model of NASH.	Hepatology	2021
32713091	Liver fibrosis: Pathophysiology and clinical implications.		2021
32763266	Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis.	J Hepatol	2021
33203939	Immunopathobiology and therapeutic targets related to cytokines in liver diseases.	Cellular and Molecular Immunology	2021
33128017	Molecular and cellular mechanisms of liver fibrosis and its regression.	Nature Reviews Gastroenterology and Hepatology	2021
34460131	Human induced pluripotent stem cell-derived macrophages ameliorate liver fibrosis.	Stem Cells	2021
34966784	The role of Mesothelin signaling in Portal Fibroblasts in the pathogenesis of cholestatic liver fibrosis.	Frontiers in Molecular Biosciences	2021
34887405	CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease.	Nat Commun	2021
32839596	Fructose stimulated de novo lipogenesis is promoted by inflammation.	Nat Metab	2020
32258954	Primary Alcohol-Activated Human and Mouse Hepatic Stellate Cells Share Similarities in Gene-Expression Profiles.	Hepatol Commun	2020
31899206	IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.	J Hepatol	2020
32051339	Blockade of IL-17 signaling reverses alcohol-induced liver injury and excessive alcohol drinking in mice.	JCI Insight	2020
31562906	Coordinated development of the mouse extrahepatic bile duct: Implications for neonatal susceptibility to biliary injury.	Journal of Hepatology	2020
31761566	Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic Steatohepatitis.	Cell Metab	2020
31982409	Identification of Lineage-Specific Transcription Factors That Prevent Activation of Hepatic Stellate Cells and Promote Fibrosis Resolution.	Gastroenterology	2020
31924111	Mechanisms of liver fibrosis and its role in liver cancer.	Experimental Biology and Medicine	2020
32492075	Pharmacological inhibition of P2RX7 ameliorates liver injury by reducing inflammation and fibrosis.	PLoS ONE	2020
32087348	Hepatic stellate cell activation promotes alcohol-induced steatohepatitis through Igfbp3 and SerpinA12.	Journal of Hepatology	2020
33210080	Traditional Chinese Medicine Fuzheng Huayu Prevents Development of Liver Fibrosis in Mice.		2020
32654263	Intestinal Virome in Patients With Alcoholic Hepatitis.	Hepatology	2020
32534258	Inhibition of prolyl hydroxylases increases hepatic insulin and decreases glucagon sensitivity by an HIF-2Î±-dependent mechanism.	Molecular Metabolism	2020
31480259	Etiology-Specific Analysis of Hepatocellular Carcinoma Transcriptome Reveals Genetic Dysregulation in Pathways Implicated in Immunotherapy Efficacy.	Cancers	2019
31693880	The Crosstalk between Hepatocytes, Hepatic Macrophages, and Hepatic Stellate Cells Facilitates Alcoholic Liver Disease.		2019
30445007	NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.	Gastroenterology	2019
30766956	Combatting Fibrosis: Exosome-Based Therapies in the Regression of Liver Fibrosis.	Hepatology Communications	2019
31184999	Human induced pluripotent stem cell-derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis.	JCI Insight	2019
31033095	Molecular Genetic and Immune Functional Responses Distinguish Bone Marrow Mesenchymal Stromal Cells from Hepatic Stellate Cells.	Stem Cells	2019
31071368	Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice.	J Hepatol	2019
30959975	The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma.	International Journal of Molecular Sciences	2019
29416609	Alcohol and hepatitis virus-dysregulated lncRNAs as potential biomarkers for hepatocellular carcinoma.	Oncotarget	2018
30061164	Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis.	Annals of the Rheumatic Diseases	2018